We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.5B
1-Year Est. Return
11.68%
This Fund
S&P 500
This Quarter
Est. Return
+2.64%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$884M
AUM Growth
+$6.79M
(+0.77%)
Cap. Flow
-$8.89M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
21.23%
Holding
269
New
8
Increased
62
Reduced
115
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.95M |
| 2 |
Amazon
AMZN
|
+$2.94M |
| 3 |
TE Connectivity
TEL
|
+$2.39M |
| 4 |
Visa
V
|
+$1.47M |
| 5 |
American Tower
AMT
|
+$1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Parker-Hannifin
PH
|
+$6.62M |
| 2 |
Oracle
ORCL
|
+$5.59M |
| 3 |
MON
Monsanto Co
MON
|
+$2.64M |
| 4 |
ExxonMobil
XOM
|
+$1.85M |
| 5 |
GE Aerospace
GE
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.41% |
| 2 | Technology | 15.55% |
| 3 | Industrials | 11.64% |
| 4 | Consumer Staples | 8.49% |
| 5 | Financials | 7.8% |
Similar funds
CP
JFGLC
AAM
TP
SCM
FMI
NSGL
RCW
Boston Family Office's Q2 2018 Portfolio in Review
As of Q2 2018, Boston Family Office held 269 positions worth $884M, up 0.77% from $877M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Boston Family Office's Q2 2018 filing shows 8 new, 62 increased, 115 reduced and 6 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M. The largest sale was Parker-Hannifin, an estimated $6.62M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.
- Boston Family Office's largest Q2 2018 buy was State Street SPDR S&P Biotech ETF: 32,150 shares worth $3.06M.
- Boston Family Office added most to Amazon in Q2 2018, an estimated $2.94M increase.
- Boston Family Office's biggest Q2 2018 reduction was Parker-Hannifin, cutting an estimated $6.62M.
- Boston Family Office fully exited Monsanto Co in Q2 2018, selling an estimated $2.64M.
- Boston Family Office's ten largest holdings make up 21% of its $884M portfolio in Q2 2018.
- Boston Family Office opened 8 new positions and closed 6 in Q2 2018.
- Boston Family Office's portfolio value rose 0.77% quarter-over-quarter to $884M.
Based on Boston Family Office's 13F filing for Q2 2018, filed 26 Jul 2018.